![Aerie Pharmaceuticals Inc - Important Information The information in this presentation does not contain all of the information that a potential investor should review before investing in Aerie shares. The descriptions of Aerie Pharmaceuticals Inc - Important Information The information in this presentation does not contain all of the information that a potential investor should review before investing in Aerie shares. The descriptions of](https://www.sec.gov/Archives/edgar/data/1337553/000119312521219618/g181545ex99_1s1g1.jpg)
Aerie Pharmaceuticals Inc - Important Information The information in this presentation does not contain all of the information that a potential investor should review before investing in Aerie shares. The descriptions of
![Aerie Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on Thursday, February 25, 2021 | Business Wire Aerie Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on Thursday, February 25, 2021 | Business Wire](https://mms.businesswire.com/media/20210218005018/en/851005/23/Aerie_Full_Color_Horizontal_%C2%AELogo_2019JUL20_F.jpg)
Aerie Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on Thursday, February 25, 2021 | Business Wire
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company's Ophthalmic Pharmaceutical Business
![Aerie Pharmaceuticals Announces Agreement to Acquire Avizorex Pharma to Advance Its Dry Eye Program | World Pharma Today Aerie Pharmaceuticals Announces Agreement to Acquire Avizorex Pharma to Advance Its Dry Eye Program | World Pharma Today](https://www.worldpharmatoday.com/wp-content/uploads/industry-reports/10435/Aerie_Pharma_acquired_Avizorex.jpg)
Aerie Pharmaceuticals Announces Agreement to Acquire Avizorex Pharma to Advance Its Dry Eye Program | World Pharma Today
![Durham-based Aerie Pharma is sold to global eye care giant in deal worth $770M - Research Triangle Regional Partnership Durham-based Aerie Pharma is sold to global eye care giant in deal worth $770M - Research Triangle Regional Partnership](https://www.researchtriangle.org/wp-content/uploads/2022/08/Aerie-picture_0-1280x640-1.jpeg)
Durham-based Aerie Pharma is sold to global eye care giant in deal worth $770M - Research Triangle Regional Partnership
![Aerie Pharmaceuticals changes HQ to Durham, giving the Triangle another public company - Triangle Business Journal Aerie Pharmaceuticals changes HQ to Durham, giving the Triangle another public company - Triangle Business Journal](https://media.bizj.us/view/img/10299903/aerie-pharmaceuticals-bldg*1200xx3024-3024-504-0.jpg)
Aerie Pharmaceuticals changes HQ to Durham, giving the Triangle another public company - Triangle Business Journal
![Aerie Pharmaceuticals (AERI) Axitinib Implant (AR-14034) Overview - Slideshow (NASDAQ:AERI) | Seeking Alpha Aerie Pharmaceuticals (AERI) Axitinib Implant (AR-14034) Overview - Slideshow (NASDAQ:AERI) | Seeking Alpha](https://static2.seekingalpha.com/uploads/sa_presentations/675/66675/slides/1.jpg?1614622890)
Aerie Pharmaceuticals (AERI) Axitinib Implant (AR-14034) Overview - Slideshow (NASDAQ:AERI) | Seeking Alpha
![Aerie Pharmaceuticals to expand R&D operations in Research Triangle Park - Triangle Business Journal Aerie Pharmaceuticals to expand R&D operations in Research Triangle Park - Triangle Business Journal](http://media.bizj.us/view/img/4037911/aerie-pharmaceuticals-4*1200xx4000-2250-0-209.jpg)